General & Plastic Surgery Devices - Argentina

In Argentina, the General & Plastic Surgery Devices market market is anticipated to witness a significant growth in revenue, with projections indicating a figure of US$339.20m by the year 2024.
Furthermore, this market is expected to exhibit a steady annual growth rate (CAGR 2024-2029) of 5.16%, ultimately leading to a market volume of US$436.30m by 2029.
When considering global comparisons, it is noteworthy that the United States is anticipated to generate the highest revenue in this market, with a projected amount of US$9.84bn in 2024.
Argentina is experiencing a surge in demand for general and plastic surgery devices, driven by a growing middle class and increased focus on cosmetic procedures.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Argentina is experiencing steady growth due to increasing customer preferences, emerging trends, and local special circumstances. Customer preferences in Argentina are driving the growth of the General & Plastic Surgery Devices market. With a growing middle class and increasing disposable income, more people are seeking aesthetic procedures to enhance their appearance. Additionally, there is a rising awareness about the availability and benefits of plastic surgery devices, leading to a higher demand for these products. Trends in the market are also contributing to its development. There is a growing trend towards minimally invasive procedures, as they offer shorter recovery times and fewer complications compared to traditional surgical methods. This has led to an increased demand for devices such as lasers, injectables, and non-surgical body contouring devices. Furthermore, technological advancements in the field of plastic surgery devices have made procedures safer and more efficient, attracting more customers. Local special circumstances in Argentina are also playing a role in the growth of the market. The country has a large population, providing a significant customer base for plastic surgery devices. Additionally, Argentina has a well-developed healthcare system, which includes specialized plastic surgery clinics and hospitals. This infrastructure supports the demand for plastic surgery devices and facilitates the growth of the market. Underlying macroeconomic factors further contribute to the development of the General & Plastic Surgery Devices market in Argentina. The country has experienced economic stability in recent years, which has boosted consumer confidence and encouraged spending on aesthetic procedures. Additionally, the government has implemented policies to support the healthcare sector, including plastic surgery, which has further fueled the growth of the market. In conclusion, the General & Plastic Surgery Devices market in Argentina is growing due to increasing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As more people seek aesthetic procedures and the demand for minimally invasive options rises, the market is expected to continue its upward trajectory in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.